Matt Kalaycio, MD, Oncology, Cleveland, OH, Cleveland Clinic

MattEKalaycioMD

Oncology Cleveland, OH

Hematologic Oncology

Bone Marrow Transplantation

Dr. Kalaycio is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kalaycio's full profile

Already have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology, 1992 - 1994
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Medical Oncology, 1991 - 1992
  • University of Pittsburgh Medical Center-Mercy Hospital
    University of Pittsburgh Medical Center-Mercy HospitalResidency, Internal Medicine, 1988 - 1991
  • West Virginia University School of Medicine
    West Virginia University School of MedicineClass of 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2018
  • MI State Medical License
    MI State Medical License 2002 - 2021
  • NY State Medical License
    NY State Medical License 2002 - 2022
  • IL State Medical License
    IL State Medical License 2002 - 2020
  • CA State Medical License
    CA State Medical License 2002 - 2020
  • CT State Medical License
    CT State Medical License 2002 - 2006
  • PA State Medical License
    PA State Medical License 1990 - 2021
  • American Board of Internal Medicine Hematology
  • Join now to see all

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
    Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
    Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
    Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Survival Outcomes of Patients with Therapy-Related Acute Myeloid Leukemia in the United States 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of CancerClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • How the COVID-19 Pandemic Has Affected Cancer Care, Research
    How the COVID-19 Pandemic Has Affected Cancer Care, ResearchMay 13th, 2020
  • Cleveland Clinic Appoints Dr. Jame Abraham as Department Chair of Hematology/Medical Oncology
    Cleveland Clinic Appoints Dr. Jame Abraham as Department Chair of Hematology/Medical OncologySeptember 23rd, 2019
  • Timed Perfectly
    Timed PerfectlyJune 1st, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations